Search Results - "Triolo, Taylor M."

Refine Results
  1. 1

    Lessons and gaps in the prediction and prevention of type 1 diabetes by Mameli, Chiara, Triolo, Taylor M., Chiarelli, Francesco, Rewers, Marian, Zuccotti, Gianvincenzo, Simmons, Kimber M.

    Published in Pharmacological research (01-07-2023)
    “…Type 1 diabetes (T1D) is a serious chronic autoimmune condition. Even though the root cause of T1D development has yet to be determined, enough is known about…”
    Get full text
    Journal Article
  2. 2

    Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes by Triolo, Taylor M, Bellin, Melena D

    Published in Frontiers in endocrinology (Lausanne) (11-03-2021)
    “…Diabetes mellitus is characterized by the body's inability to control blood glucose levels within a physiological range due to loss and/or dysfunction of…”
    Get full text
    Journal Article
  3. 3

    Longitudinal Quality of Life and Glycemic Outcomes of Total Pancreatectomy With Islet Autotransplantation in Children With Chronic Pancreatitis Followed in a Pediatric Multidisciplinary Pancreas Clinic by Khatter, Neil J., Hum, Stephanie W., Mark, Jacob A., Forlenza, Gregory, Triolo, Taylor M.

    Published in Pediatric transplantation (01-08-2024)
    “…ABSTRACT Background Total pancreatectomy with islet autotransplantation (TPIAT) is a potentially curative treatment for patients with chronic pancreatitis (CP)…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Stem-Cell-Derived β-Like Cells with a Functional PTPN2 Knockout Display Increased Immunogenicity by Triolo, Taylor M, Matuschek, J Quinn, Castro-Gutierrez, Roberto, Shilleh, Ali H, Williams, Shane P M, Hansen, Maria S, McDaniel, Kristen, Barra, Jessie M, Michels, Aaron, Russ, Holger A

    Published in Cells (Basel, Switzerland) (30-11-2022)
    “…Type 1 diabetes is a polygenic disease that results in an autoimmune response directed against insulin-producing beta cells. is a known high-risk type 1…”
    Get full text
    Journal Article
  6. 6

    Diabetic Subjects Diagnosed Through the Diabetes Prevention Trial-Type 1 (DPT-1) Are Often Asymptomatic With Normal A1C at Diabetes Onset by Triolo, Taylor M, Chase, H. Peter, Barker, Jennifer M

    Published in Diabetes care (01-05-2009)
    “…OBJECTIVE: Upon diagnosis of type 1 diabetes, patients are usually symptomatic, and many have ketoacidosis. Screening for islet autoantibodies (IAs) has been…”
    Get full text
    Journal Article
  7. 7

    Proinsulin:C-peptide ratio trajectories over time in relatives at increased risk of progression to type 1 diabetes by Triolo, Taylor M., Pyle, Laura, Seligova, Sona, Yu, Liping, Simmons, Kimber, Gottlieb, Peter, Evans-Molina, Carmella, Steck, Andrea K.

    “…Biomarkers are needed to characterize heterogeneity within populations at risk for type 1 diabetes. The ratio of proinsulin to C-peptide (PI:C ratio), has been…”
    Get full text
    Journal Article
  8. 8

    161-LB: Diagnosis and Treatment of Diabetes Mellitus in Pediatric Patients with Pancreatitis Followed in a Multidisciplinary Clinic by VARGAS, ELIZABETH, MARK, JACOB, FORLENZA, GREGORY P., TRIOLO, TAYLOR M.

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Children with recurring acute or chronic pancreatitis are at risk for pancreatitis related diabetes mellitus (DM). Pancreatic endocrine and exocrine concerns…”
    Get full text
    Journal Article
  9. 9

    1617-P: Association of High-Affinity Autoantibodies with High-Risk HLA Haplotypes by TRIOLO, TAYLOR M., PYLE, LAURA, YU, LIPING, GOTTLIEB, PETER, STECK, ANDREA

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Electrochemiluminescence (ECL) assays are high-affinity autoantibodies (Abs) that are more specific than radiobinding assay (RBA) Abs for the prediction of…”
    Get full text
    Journal Article
  10. 10

    Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes by Triolo, Taylor M, Pyle, Laura, Broncucia, Hali, Armstrong, Taylor, Yu, Liping, Gottlieb, Peter A, Steck, Andrea K

    “…Electrochemiluminescence (ECL) assays are high-affinity autoantibody (Ab) tests that are more specific than Abs detected by traditional radiobinding assays…”
    Get full text
    Journal Article
  11. 11

    Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population by Alonso, G Todd, Triolo, Taylor M, Akturk, Halis Kaan, Pauley, Meghan E, Sobczak, Marisa, Forlenza, Gregory P, Sakamoto, Casey, Pyle, Laura, Frohnert, Brigitte I

    Published in Diabetes care (01-06-2023)
    “…While continuous glucose monitors (CGMs), insulin pumps, and hybrid closed-loop (HCL) systems each improve glycemic control in type 1 diabetes, it is unclear…”
    Get full text
    Journal Article
  12. 12

    1125-P: Do Non-HLA Genes Contribute to Age of Type 1 Diabetes Onset in Monozygotic Twins? by TRIOLO, TAYLOR M., DONG, FRAN, BRONCUCIA, HALI C., ONENGUT-GUMUSCU, SUNA, STECK, ANDREA, RICH, STEPHEN S.

    Published in Diabetes (New York, N.Y.) (01-06-2021)
    “…Development of islet autoimmunity (IA) and type 1 diabetes (T1D) are associated with high-risk HLA class II loci as well as non-HLA genes. Monozygotic (MZ)…”
    Get full text
    Journal Article
  13. 13

    Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives by Triolo, Taylor M, Parikh, Hemang M, Tosur, Mustafa, Ferrat, Lauric, You, Lu, Gottlieb, Peter A, Oram, Richard A, Onengut-Gumuscu, Suna, Krischer, Jeffrey P, Rich, Stephen S, Steck, Andrea K, Redondo, Maria J

    “…We sought to determine whether the type 1 diabetes genetic risk score-2 (T1D-GRS2) and single nucleotide polymorphisms (SNPs) are associated with C-peptide…”
    Get full text
    Journal Article
  14. 14

    1254-P: Genetic Prediction of C-Peptide Trajectory before Type 1 Diabetes Diagnosis in TrialNet by TRIOLO, TAYLOR M., PARIKH, HEMANG M., TOSUR, MUSTAFA, GOTTLIEB, PETER, ORAM, RICHARD A., ONENGUT-GUMUSCU, SUNA, KRISCHER, JEFFREY, RICH, STEPHEN S., STECK, ANDREA, REDONDO, MARIA J.

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…Modeling the course of C-peptide decline in autoantibody (Ab) positive individuals is important for type 1 diabetes (T1D) prediction and implementation of T1D…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    216-LB: Genetic Influences on Beta-Cell Function before Type 1 Diabetes Diagnosis by TRIOLO, TAYLOR M., PARIKH, HEMANG M., TOSUR, MUSTAFA, FERRAT, LAURIC A., YOU, LU, GOTTLIEB, PETER, ORAM, RICHARD A., ONENGUT-GUMUSCU, SUNA, KRISCHER, JEFFREY, RICH, STEPHEN S., STECK, ANDREA, REDONDO, MARIA J.

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Autoimmune loss of beta-cell function (measured by C-peptide) is the hallmark of type 1 diabetes (T1D) targeted by interventions that aim to prevent T1D or its…”
    Get full text
    Journal Article
  18. 18

    Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset by Triolo, Taylor M, Armstrong, Taylor K, McFann, Kim, Yu, Liping, Rewers, Marian J, Klingensmith, Georgeanna J, Eisenbarth, George S, Barker, Jennifer M

    Published in Diabetes care (01-05-2011)
    “…OBJECTIVE: We sought to define the prevalence of nonislet, organ-specific autoantibodies at diagnosis of type 1 diabetes and to determine the prevalence of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Etiology of Insulin Resistance in Youth with Type 2 Diabetes by Cree-Green, Melanie, Triolo, Taylor M., Nadeau, Kristen J.

    Published in Current diabetes reports (01-02-2013)
    “…Type 2 diabetes (T2DM), historically an adult disease, is now increasingly prevalent in obese youth. Poor diet and increased sedentary behavior contribute to…”
    Get full text
    Journal Article